EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY-NC-ND 4.0

Identification of a Second‐Hit Brain Somatic DEPDC5 Variant Supports Causality of a DEPDC5 Germline Variant of Uncertain Significance. Time for a Classification Update?

Ala'a Alsayed, Zainab Hakim, Daria Merrikh, Maryam Khanbabaei, Navprabhjot Kaur, Walter Hader, Tyler Soule, Setareh Ashtiani, Grace Polanco-Tovar, Morris Scantlebury, Hamed Rahi, Yang Cao iD und 5 weitere

American Journal of Medical Genetics Part A · 2025-12 · 197 (12)

DOI: 10.1002/ajmg.a.64204 ↗

Kurz gefasst

Fallbericht in der Zeitschrift American Journal of Medical Genetics Part A, online erschienen am 31.07.2025. Verfasst von Ala'a Alsayed und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Neurosciences, University of Calgary, Calgary, Alberta, Canada. Hauptthemen laut MEDLINE: Germ-Line Mutation, GTPase-Activating Proteins, Epilepsies, Partial, Genetic Predisposition to Disease. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Canada brain research fund, Health Canada, Fondation Brain Canada.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Germline variants in DEPDC5 are a cause of familial focal epilepsy with variable foci. Affected individuals may have focal cortical dysplasia if a second brain somatic variant occurs. As access to brain tissue is limited, the second somatic hit in the brain is usually presumed if a clear pathogenic germline variant is present. Here, we present a patient with structural focal epilepsy due to focal cortical dysplasia. He underwent epilepsy surgery at age 2 months. Clinical genetic testing revealed a germline variant of uncertain significance (VUS) DEPDC5 c.920T>G, p. (Leu307Arg). We hypothesized that if the proband's germline DEPDC5 variant was disease‐causal, a second somatic variant may be identifiable in affected cortical tissue. DNA was extracted from archived brain formalin‐fixed paraffin‐embedded tissue and subjected to deep gene panel analysis. This revealed an additional somatic pathogenic variant in DEPDC5 , which was confirmed using droplet digital PCR. Identification of the second somatic hit in brain tissue ( DEPDC5 c.982C>T, p.(Arg328*)) confirmed the two‐hit situation in this patient and supported disease causality of the germline variant. In conclusion, testing tissue for somatic variants may be clinically relevant at a patient‐specific level if a germline VUS affects a gene where a two‐hit mechanism is known.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Germ-Line MutationGTPase-Activating ProteinsEpilepsies, PartialGenetic Predisposition to DiseaseMalformations of Cortical DevelopmentHumansMaleBrainInfant

Stichwörter der Autor:innen

brain tissueepilepsyfocal cortical dysplasiageneticsgermline variantsomatic varianttwo‐hit

Substanzen

GTPase-Activating ProteinsDEPDC5 protein, human

Autor:innen und Institutionen

  • Department of Clinical Neurosciences, University of Calgary, Calgary, Alberta, Canada.
  • Hotchkiss Brain Institute, University of Calgary, Calgary, Alberta, Canada.
  • Alberta Children's Hospital Research Institute, University of Calgary, Calgary, Alberta, Canada.
  • Department of Medical Genetics, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
  • Department of Pediatrics, University of Calgary, Alberta Children's Hospital, Calgary, Alberta, Canada.
  • Department of Pathology and Immunology, Washington University in St. Louis School of Medicine, St. Louis, Missouri, USA.

ORCID-Profile: Yang Cao, Karl Martin Klein

Förderung

  • Canada brain research fund
  • Health Canada
  • Fondation Brain Canada
  • Azrieli Foundation
  • Epilepsy Canada
  • Hotchkiss Brain Institute, University of Calgary
  • Alberta Children's Hospital Research Institute
  • Canada Foundation for Innovation

Zitieren

APA

Alsayed, A., Hakim, Z., Merrikh, D., Khanbabaei, M., Kaur, N., Hader, W., Soule, T., Ashtiani, S., Polanco-Tovar, G., Scantlebury, M., Rahi, H., Cao, Y., Chan, J. A., Appendino, J. P., Pfeffer, G., Au, P. Y. B., & Klein, K. M. (2025). Identification of a Second‐Hit Brain Somatic DEPDC5 Variant Supports Causality of a DEPDC5 Germline Variant of Uncertain Significance. Time for a Classification Update?. American Journal of Medical Genetics Part A, 197(12). https://doi.org/10.1002/ajmg.a.64204

Vancouver

Alsayed A, Hakim Z, Merrikh D, Khanbabaei M, Kaur N, Hader W, et al. Identification of a Second‐Hit Brain Somatic DEPDC5 Variant Supports Causality of a DEPDC5 Germline Variant of Uncertain Significance. Time for a Classification Update?. American Journal of Medical Genetics Part A. 2025;197(12). doi:10.1002/ajmg.a.64204

BibTeX
@article{Alsayed2025,
  author = {Alsayed, Ala'a and Hakim, Zainab and Merrikh, Daria and Khanbabaei, Maryam and Kaur, Navprabhjot and Hader, Walter and Soule, Tyler and Ashtiani, Setareh and Polanco-Tovar, Grace and Scantlebury, Morris and Rahi, Hamed and Cao, Yang and Chan, Jennifer A and Appendino, Juan P and Pfeffer, Gerald and Au, Ping Yee Billie and Klein, Karl Martin},
  title = {Identification of a Second‐Hit Brain Somatic DEPDC5 Variant Supports Causality of a DEPDC5 Germline Variant of Uncertain Significance. Time for a Classification Update?},
  journal = {American Journal of Medical Genetics Part A},
  year = {2025},
  volume = {197},
  number = {12},
  doi = {10.1002/ajmg.a.64204}
}
Kostenlos starten →